Matches in Wikidata for { <http://www.wikidata.org/entity/Q91676975> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q91676975 description "artículu científicu espublizáu en xunetu de 2019" @default.
- Q91676975 description "im Juli 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91676975 description "scientific article published on 04 July 2019" @default.
- Q91676975 description "wetenschappelijk artikel" @default.
- Q91676975 description "наукова стаття, опублікована 4 липня 2019" @default.
- Q91676975 name "Increased infection rates associated with tetracycline therapy given for epidermal growth factor receptor inhibitor (EGFRI)-associated acneiform eruption: A retrospective study of data from two cancer centers" @default.
- Q91676975 name "Increased infection rates associated with tetracycline therapy given for epidermal growth factor receptor inhibitor (EGFRI)-associated acneiform eruption: A retrospective study of data from two cancer centers" @default.
- Q91676975 type Item @default.
- Q91676975 label "Increased infection rates associated with tetracycline therapy given for epidermal growth factor receptor inhibitor (EGFRI)-associated acneiform eruption: A retrospective study of data from two cancer centers" @default.
- Q91676975 label "Increased infection rates associated with tetracycline therapy given for epidermal growth factor receptor inhibitor (EGFRI)-associated acneiform eruption: A retrospective study of data from two cancer centers" @default.
- Q91676975 prefLabel "Increased infection rates associated with tetracycline therapy given for epidermal growth factor receptor inhibitor (EGFRI)-associated acneiform eruption: A retrospective study of data from two cancer centers" @default.
- Q91676975 prefLabel "Increased infection rates associated with tetracycline therapy given for epidermal growth factor receptor inhibitor (EGFRI)-associated acneiform eruption: A retrospective study of data from two cancer centers" @default.
- Q91676975 P1433 Q91676975-52B98159-979C-4FA8-A77F-03F168D1ADA1 @default.
- Q91676975 P1476 Q91676975-BCA97C66-6083-4808-BF21-C04CBCD29BEB @default.
- Q91676975 P2093 Q91676975-134E9240-48D4-4F79-B84E-5C88AA093C93 @default.
- Q91676975 P2093 Q91676975-783A0EF0-4B3C-4BEE-9F48-66BED0F5A4B3 @default.
- Q91676975 P2093 Q91676975-A868AFB1-0D74-4D9A-BBF0-DA7E4495D653 @default.
- Q91676975 P2093 Q91676975-D8189DB7-D1A0-48EB-AB0D-9F3C16FFDD95 @default.
- Q91676975 P304 Q91676975-EFC39939-8C87-4F58-B0DD-298B98E294F5 @default.
- Q91676975 P31 Q91676975-1F1E76AB-95A4-441A-B391-222573CED871 @default.
- Q91676975 P356 Q91676975-003B66F0-359E-403F-8FC6-6057BFB9BEBB @default.
- Q91676975 P433 Q91676975-ABD83668-CFB8-4FFB-9584-BBF1F9401444 @default.
- Q91676975 P478 Q91676975-02334294-2E75-4F38-B72F-99CEDF1EE840 @default.
- Q91676975 P577 Q91676975-5C61C7F3-3F2E-4CF6-8B30-EACD02212590 @default.
- Q91676975 P698 Q91676975-A97464E5-6B3E-40C1-AD71-6E59F0066357 @default.
- Q91676975 P921 Q91676975-46EA1FE0-4F81-4A2B-AA13-E9717DE447A8 @default.
- Q91676975 P921 Q91676975-D6ED9115-CEFE-4021-9FE3-B5F6DD5A09D2 @default.
- Q91676975 P356 J.JAAD.2019.06.1310 @default.
- Q91676975 P698 31279812 @default.
- Q91676975 P1433 Q15757046 @default.
- Q91676975 P1476 "Increased infection rates associated with tetracycline therapy given for epidermal growth factor receptor inhibitor (EGFRI)-associated acneiform eruption: A retrospective study of data from two cancer centers" @default.
- Q91676975 P2093 "Cynthia M C DeKlotz" @default.
- Q91676975 P2093 "David J Perry" @default.
- Q91676975 P2093 "Deepa S Subramaniam" @default.
- Q91676975 P2093 "Michele Z Magnino" @default.
- Q91676975 P304 "486-488" @default.
- Q91676975 P31 Q13442814 @default.
- Q91676975 P356 "10.1016/J.JAAD.2019.06.1310" @default.
- Q91676975 P433 "2" @default.
- Q91676975 P478 "82" @default.
- Q91676975 P577 "2019-07-04T00:00:00Z" @default.
- Q91676975 P698 "31279812" @default.
- Q91676975 P921 Q193045 @default.
- Q91676975 P921 Q2365426 @default.